Olympus Corporation OCPNY
18.00 +18.00
Day range unavailable
52-week range unavailable
6M -3.40 (-15.90%)
News
UroGen's Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer 
Stocks That Hit 52-Week Highs On Tuesday 
Stocks That Hit 52-Week Highs On Thursday 
Stocks That Hit 52-Week Highs On Wednesday - Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Friday - Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Friday 
Stocks That Hit 52-Week Highs On Friday
Your note
Sign in to keep a note on OCPNY — it syncs with the Stock Master app.